Sebia invites you to their event

Multiple Myeloma clinical cases at diagnosis and monitoring according to latest IMWG recommendations

About this event

Abstract

Multiple myeloma is the second most common hematologic malignancy. In Multiple myeloma a serum or urine monoclonal component is produced by bone marrow plasma cells. Great progresses have been made in the latest 10 years and survivals are nearly doubled. This improvement has been reached with novel efficacious drugs and with implemented diagnostic tools. The diagnosis is made by serum and urine biochemicals exams, by radiological examination and by marrow analysis. Novel diagnostic parameters have been introduced and novel prognosticators are present. Cytogenetics , flow cytometry, PET-CT are only few of them. Laboratory tools are present that can diagnose, detect and monitor disease during follow up. In this presentation an overview of multiple myeloma diagnostic and therapeutic tools will be given according to recent IMWG recommendations and with practical clinical cases discussed.

Speaker's biography

Dr Alessandro Gozzetti gained his medical degree in 1993 and hematology fellowship in 1997 from Bologna University, Italy. He completed at the same University a PhD in oncology in 2001. He worked as research fellow 3 years at University of Chicago at the Molecular Cytogenetic Cancer Center lab led by Dr Janet Rowley and Michelle Le Beau.He is actually Associate Professor at the Division of Hematology of University of Siena,Italy. He is also Director of the Molecular Cytogenetic Lab at the same division since 2001. He has been involved in multiple myeloma treatment and research since 1997.He participated in several multiple myeloma trials as PI and was in the writing committee in many. He recently led a national research on CNS myeloma that was published in Cancer.He is member of the International Myeloma Working Group (IMWG) and participated actively to several papers. He is within the founders of the Multiple Myeloma Tuscan Group. He published over 170 papers in hematology mostly in the field of Multiple Myeloma.

Hosted by

  • Guest speaker
    AG G
    Alessandro Gozzetti MD, PhD

  • Team member
    T
    Samuel Paixao Global Product Manager - Multiple Myeloma @ Sebia

Sebia

The new language of Life.

Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.

body{font-family: 'Poppins', sans-serif;}